基质金属蛋白酶与垂体腺瘤的侵袭性
摘要
基质金属蛋白酶(MMPs)是一大类细胞外基质降解酶,影响肿瘤的侵袭和转移。对侵袭性垂体腺瘤来说,MMPs尤其是MMPs-9与其侵袭性关系密切,本文就该方面及MMPs的分类、特性等作一概述。
出处
《中国微侵袭神经外科杂志》
CAS
2003年第2期94-96,共3页
Chinese Journal of Minimally Invasive Neurosurgery
参考文献16
-
1[1]Turner HE, Nagy Zs, Esiri MM, et al. Role of matrix metalloproteinase 9 in pituitary tumor behavior [J]. J Clinical Endocrinology and metabolism, 2000; 85(8): 2931-2935.
-
2[2]Kawamoto H, Uozumi T, Kawamtot K, et al. Type Ⅳ collagenase activity and cavernous sinus invasion in human pituitary adenomas [J]. Acta Neurochir(Wien), 1996; 138(4):390-395.
-
3[3]Tipton KF. Agavain a metalloproteinase [J]. Biochim Biophys Acta, 1965; 110(2): 414-422.
-
4[4]Johansson N, Ahonen M, Kahari VM, et al. Matrix Metalloproteinase in tumor invasion [J]. Cell Mol Life Sci, 2000; 57(1):5-15.
-
5[5]Westermarck J, Kahari VM. Regulation of matrix metalloproteinases expression in tumor invasion [J]. FASEB J, 1999; 13(8): 781-792.
-
6[6]Knauper Ⅴ, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2)are able to generate active enzyme [J]. J Biol Chem, 1996;271(29): 17124-17131.
-
7[7]Zucker S, Lysik RM, Moll U. M(r) 92 000 type Ⅳ collagenase is increased in plasma of patients with colon cancer and breast cancer [J]. Cancer Res, 1993; 53(1): 140-146.
-
8[8]Yamamoto M, Mohanam S, Sawaya R, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human [J]. Cancer Res, 1996; 56(2): 384-392.
-
9[9]Deryugina EI, Luo GX, Reisfeld RA, et al. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2 [J]. Anticancer Res, 1997; 17(5A): 3201-3210.
-
10[10]Charoenrat P, Modjtahedi H, Rhys-Evans P, et al. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells [J]. Cancer Res, 2000; 60(4): 1121-1128.
-
1周任,柏鲁宁,王睿智,张龙洲,包新杰,曹杰.基质金属蛋白酶-2及其抑制因子TIMP-2在脑胶质瘤中的表达及意义[J].西安交通大学学报（医学版）,2008,29(6):686-688. 被引量：2
-
2王淑惠,汤华晓,毕景春,陈芳,潘丽.基质金属蛋白酶MMP-9基质金属蛋白酶抑制剂TIMP-1与血管内皮生长因子在非小细胞肺癌侵袭转移过程中的关系研究[J].河北医学,2011,17(12):1563-1567. 被引量：13
-
3黄秋香.子宫肌瘤患者中TIMP-3和MMP-13的检测意义[J].中国优生与遗传杂志,2014,22(12):26-27.
-
4夏鹤春,买正军,马泽,郝少才.基质金属蛋白酶及其抑制因子在脑胶质瘤侵袭性中的作用[J].山东医药,2006,46(15):1-2.
-
5历春,顾晓琪,盖晓东.MMP-14和TIMP-2在结直肠癌组织中的表达及其临床意义[J].吉林大学学报（医学版）,2012,38(5):990-994.
-
6范蕊芳,方志刚,刘相富,郑永江,刘彬彬,郭小燕,林东军.基质金属蛋白酶抑制因子3甲基化与急性白血病的相关性研究[J].国际内科学杂志,2009,36(2):67-68. 被引量：1
-
7孙鹏,笪冀平.肺癌侵袭、转移相关基因MMP-2、CD147、TIMP-2的表达与CT征象相关性[J].中日友好医院学报,2009,23(3):189-191. 被引量：1
-
8王宏,李宏丹,苏荣健,黄克强.特异性下调葡萄糖调节蛋白78降低人涎腺腺样囊性癌侵袭和转移的能力[J].解剖学报,2010,41(6):847-851. 被引量：1
-
9李健宁,徐忠法.结直肠癌侵袭转移相关基因的研究进展[J].山东医药,2015,55(25):98-100. 被引量：4
-
10段树锋,朱新群.MMP3与TIMP2蛋白在宫颈癌中的表达及意义[J].中国实用医药,2008,3(12):28-30. 被引量：5
